Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mena CI"'
Autor:
Maxime Mistretta, Mena Cimino, Pascal Campagne, Stevenn Volant, Etienne Kornobis, Olivier Hebert, Christophe Rochais, Patrick Dallemagne, Cédric Lecoutey, Camille Tisnerat, Alban Lepailleur, Yann Ayotte, Steven R. LaPlante, Nicolas Gangneux, Monika Záhorszká, Jana Korduláková, Sophie Vichier-Guerre, Frédéric Bonhomme, Laura Pokorny, Marvin Albert, Jean-Yves Tinevez, Giulia Manina
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-22 (2024)
Abstract Drug-recalcitrant infections are a leading global-health concern. Bacterial cells benefit from phenotypic variation, which can suggest effective antimicrobial strategies. However, probing phenotypic variation entails spatiotemporal analysis
Externí odkaz:
https://doaj.org/article/fa9c75f3b4af4a52a3bae94cff9e5192
Publikováno v:
BMC Genomics, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Tuberculosis (TB) is caused by Mycobacterium tuberculosis and represents one of the major challenges facing drug discovery initiatives worldwide. The considerable rise in bacterial drug resistance in recent years has led to the ne
Externí odkaz:
https://doaj.org/article/9d539ce22669430e9264ba01e6742a5a
Autor:
Olga Mestre, Raquel Hurtado-Ortiz, Tiago Dos Vultos, Amine Namouchi, Mena Cimino, Madalena Pimentel, Olivier Neyrolles, Brigitte Gicquel
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53486 (2013)
Mycobacterium tuberculosis has the remarkable capacity to survive within the hostile environment of the macrophage, and to resist potent antibacterial molecules such as reactive oxygen species (ROS). Thus, understanding mycobacterial resistance mecha
Externí odkaz:
https://doaj.org/article/81f705ad3b37454c986a168e7f3abf31
Autor:
Mena Cimino, Christophe Thomas, Amine Namouchi, Sarah Dubrac, Brigitte Gicquel, Deshmukh N Gopaul
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42876 (2012)
BACKGROUND: The Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system controls the expression of about 2% of the genome and plays a major role in pathogenicity. However, its regulon has not been well characterized. METHODOLOGY
Externí odkaz:
https://doaj.org/article/ee6047195d9a44e28905324457ed7d39
Autor:
Prasad M (AUTHOR), Buller GK (AUTHOR), Mena CI (AUTHOR), Sofair AN (AUTHOR), Prasad, Meeta1 (AUTHOR), Buller, Gregory K (AUTHOR), Mena, Carlos I (AUTHOR), Sofair, André N (AUTHOR)
Publikováno v:
New England Journal of Medicine. 12/7/2006, Vol. 355 Issue 23, p2468-2473. 6p.
Publikováno v:
Mena, C I, Lang, K & Gherri, E 2020, ' Electrophysiological correlates of attentional selection in tactile search tasks : The impact of singleton distractors on target selection ', Psychophysiology, vol. 57, no. 9, pp. 1-12 . https://doi.org/10.1111/psyp.13592
Mena, C I, Lang, K & Gherri, E 2020, ' Electrophysiological correlates of attentional selection in tactile search tasks : The impact of singleton distractors on target selection ', Psychophysiology . https://doi.org/10.1111/psyp.13592
Mena, C I, Lang, K & Gherri, E 2020, ' Electrophysiological correlates of attentional selection in tactile search tasks : The impact of singleton distractors on target selection ', Psychophysiology . https://doi.org/10.1111/psyp.13592
Recent event-related potential (ERP) studies have suggested that the N140cc component reflects target-selection mechanisms in tactile search tasks in which the target is presented simultaneously with homogeneous distractors. To investigate if and how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514714fa2bb8e6983b807775aae1050e
https://www.pure.ed.ac.uk/ws/files/191922321/MenaEtal2020PElectrophysiologicalCorrelatesOfAttentionalSelection.pdf
https://www.pure.ed.ac.uk/ws/files/191922321/MenaEtal2020PElectrophysiologicalCorrelatesOfAttentionalSelection.pdf
Autor:
Mena CI; Human Cognitive Neuroscience, Psychology, University of Edinburgh, Edinburgh, United Kingdom., Lang K; Human Cognitive Neuroscience, Psychology, University of Edinburgh, Edinburgh, United Kingdom., Gherri E; Human Cognitive Neuroscience, Psychology, University of Edinburgh, Edinburgh, United Kingdom.
Publikováno v:
Psychophysiology [Psychophysiology] 2020 Sep; Vol. 57 (9), pp. e13592. Date of Electronic Publication: 2020 May 15.
Autor:
Huang C; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut., Li SX; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut., Mahajan S; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut.; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Testani JM; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Wilson FP; Program of Applied Translational Research, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Mena CI; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Masoudi FA; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora., Rumsfeld JS; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora., Spertus JA; Saint Luke's Mid America Heart Institute, Department of Cardiology, University of Missouri, Kansas City., Mortazavi BJ; Department of Computer Science and Engineering, Texas A&M University, College Station., Krumholz HM; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut.; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
Publikováno v:
JAMA network open [JAMA Netw Open] 2019 Nov 01; Vol. 2 (11), pp. e1916021. Date of Electronic Publication: 2019 Nov 01.
Autor:
Mena CI; National Unit of Clozapine Pharmacovigilance, J. Horwitz Psychiatric Institute.; Early Intervention in Psychosis Program, J. Horwitz Psychiatric Institute., Nachar RA; Early Intervention in Psychosis Program, J. Horwitz Psychiatric Institute.; School of Medicine, Universidad Finis Terrae., Crossley NA; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., González-Valderrama AA; Early Intervention in Psychosis Program, J. Horwitz Psychiatric Institute.; School of Medicine, Universidad Finis Terrae.
Publikováno v:
International clinical psychopharmacology [Int Clin Psychopharmacol] 2019 Sep; Vol. 34 (5), pp. 257-263.
Autor:
Huang C; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Murugiah K; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America., Mahajan S; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Li SX; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Dhruva SS; Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America., Haimovich JS; Albert Einstein College of Medicine, Bronx, New York, United States of America., Wang Y; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Schulz WL; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America.; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America., Testani JM; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America., Wilson FP; Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America., Mena CI; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America., Masoudi FA; Division of Cardiology, School of Medicine, University of Colorado, Aurora, Colorado, United States of America., Rumsfeld JS; Division of Cardiology, School of Medicine, University of Colorado, Aurora, Colorado, United States of America., Spertus JA; Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States of America., Mortazavi BJ; Department of Computer Science & Engineering, Texas A&M University, College Station, Texas, United States of America., Krumholz HM; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America.; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.
Publikováno v:
PLoS medicine [PLoS Med] 2018 Nov 27; Vol. 15 (11), pp. e1002703. Date of Electronic Publication: 2018 Nov 27 (Print Publication: 2018).